• 4166 Citations
  • 38 h-Index
1992 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Stefano Indraccolo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Neoplasms Medicine & Life Sciences
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Genetic Therapy Medicine & Life Sciences
Heterografts Medicine & Life Sciences
SCID Mice Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Tumors Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

  • 4166 Citations
  • 38 h-Index
  • 150 Article
  • 2 Short survey
  • 1 Chapter
  • 1 Review article

Dissecting molecular mechanisms of resistance to Notch1-targeted therapy in T-cell acute lymphoblastic leukemia xenografts

Agnusdei, V., Minuzzo, S., Pinazza, M., Gasparini, A., Pezzè, L., Amaro, A. A., Pasqualini, L., Del Bianco, P., Tognon, M., Frasson, C., Palumbo, P., Ciribilli, Y., Pfeffer, U., Carella, M., Amadori, A. & Indraccolo, S., Aug 29 2019, In : Haematologica.

Research output: Contribution to journalArticle

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Heterografts
Therapeutics
Notch Receptors
Mutation

Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts

Ricci, F., Brunelli, L., Affatato, R., Chilà, R., Verza, M., Indraccolo, S., Falcetta, F., Fratelli, M., Fruscio, R., Pastorelli, R. & Damia, G., 2019, In : Therapeutic Advances in Medical Oncology. 11, p. 1758835919839543

Research output: Contribution to journalArticle

Platinum
Heterografts
Ovarian Neoplasms
Metabolomics
Smegmamorpha

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

Lombardi, G., De Salvo, G. L., Brandes, A. A., Eoli, M., Rudà, R., Faedi, M., Lolli, I., Pace, A., Daniele, B., Pasqualetti, F., Rizzato, S., Bellu, L., Pambuku, A., Farina, M., Magni, G., Indraccolo, S., Gardiman, M. P., Soffietti, R. & Zagonel, V., Jan 2019, In : The Lancet. Oncology. 20, 1, p. 110-119 10 p.

Research output: Contribution to journalArticle

Lomustine
Glioblastoma
Survival
temozolomide
Italy

Genetic, epigenetic and immunologic profiling of MMR-deficient relapsed glioblastoma

Indraccolo, S., Lombardi, G., Fassan, M., Pasqualini, L., Giunco, S., Marcato, R., Gasparini, A., Candiotto, C., Nalio, S., Fiduccia, P., Fanelli, G. N., Pambuku, A., Della Puppa, A., D'Avella, D., Bonaldi, L., Gardiman, M. P., Bertorelle, R., De Rossi, A. & Zagonel, V., Dec 4 2018, In : Clinical Cancer Research.

Research output: Contribution to journalArticle

DNA Mismatch Repair
Glioblastoma
Epigenomics
Tumor Burden
Exome

Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells

Pinazza, M., Ghisi, M., Minuzzo, S., Agnusdei, V., Fossati, G., Ciminale, V., Pezzè, L., Ciribilli, Y., Pilotto, G., Venturoli, C., Amadori, A. & Indraccolo, S., Jul 2018, In : Oncogene. 37, 28, p. 3839-3851 13 p.

Research output: Contribution to journalArticle

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Histone Deacetylases
trichostatin A
Neoplasms
Apoptosis